HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Gold Sodium Thiomalate

HCID 22318
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
12244-57-4
Standard SMILES
O=C([O-])CC([S-])C(=O)[O-].[Au+].[Na+].[Na+]
InChIKey
VXIHRIQNJCRFQX-UHFFFAOYSA-K
Molecular formula
C4H3AuNa2O4S
Average molar mass
390.08 g/mol
Monoisotopic mass
389.921313

Overview

Disodium aurothiomalate is an organic sodium salt which is the disodium salt of gold thiomalic acid, with a basic unit comprising two sodium cations and a divalent aurothiomalate anion. It contains an aurothiomalate(2-).

Names & identifiers

Preferred name
Gold Sodium Thiomalate
IUPAC
disodium;gold(1+);2-sulfidobutanedioate
English name
Sodium aurothiomalate
Molecular formula
C4H7AuNaO4S
Molecular weight
371.11

Names & synonyms

Sodium aurothiomalateTauredonGOLD SODIUM THIOMALATE12244-57-4ChrysothiosMyocrisinKidonMyochrysineAurothiomalate sodiumNatrii aurothiomalasAurothiomalate de sodiumAurothiomalate Disodium
Show more names
SODIUM AUROTHIOMALATE(I)autmD00992miochrysinMiocrisinaMyocrisine
AurolateButanedioic acid, mercapto-, monogold(1+) sodium saltE4768ZY6GMdisodium 2-(auriosulfanyl)butanedioateMyocrysineMiocrisinSodium Gold ThiomalateSodium Thiomalatoaurate

Database identifiers

CAS
12244-57-4
PubChem CID
22318
ChEMBL
CHEMBL306043
ChEBI
CHEBI:35864
EC Number
235-479-7

Properties

Computed structural properties

Topological polar surface area
81.3 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
5
Rotatable bonds
1
Heavy atoms
12
Formal charge
0
Complexity
126

Experimental & physicochemical properties

OdorOdorless
TasteMetallic taste
Color/FormWhite to yellowish-white powder; mixture of mono- and disodium salts
SolubilityVery soluble in water; practically insoluble in alcohol, ether
Human DrugsBreast Feeding; Lactation; Milk, Human; Antirheumatic Agents
Stability/Shelf LifeFollowing the date of manufacture, ... gold sodium thiomalate injection /has an expiration date/ of 5 years.
Other Experimental Properties · 2 items

Aqueous solutions are colorless to pale yellow; pH of 5% aq solution: 5.8-6.5

Affected by light

Physicochemical properties

storage temp.
4 °C, · 4°C, away from moisture
form
Solid
color
Off-white to light yellow

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 6 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Other Safety InformationIMAP assessments - Butanedioic acid, mercapto-, monogold(1+) sodium salt: Human health tier I assessment

Safety & protection

Storage Conditions... Gold sodium thiomalate injection should be protected from light and stored at a temperature less than 40C, preferably at 1530C; freezing should be avoided.
Disposal Methods · 1 item

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Toxicology

Milk ConcentrationsSmall amounts of gold have been shown to be distributed into milk in women receiving ... gold sodium thiomalate.

Chemistry & industry

Pharmacology

ATC Code · 2 items

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingAbout 85-90% of the drug is protein bound.
PharmacodynamicsUnknown, may decrease prostaglandin synthesis or may alter cellular mechanisms by inhibiting sulfhydryl systems.
Mechanism of Action · 4 items

The precise mechanism of action is unknown. It is known that sodium aurothiomalate inhibits the synthesis of prostaglandins. The predominant action appears to be a suppressive effect on the synovitis of active rheumatoid disease.

...The effects of aurothiomalate, on basal and forskolin-activated adenylyl cyclase activity in human total lymphocyte membranes and in membranes of T and B lymphocyte subsets /was studied/. The gold compounds inhibited adenylyl cyclase activity. This inhibitory effect required the presence of both the sulfhydryl ligands and aurous cation. Regulation of lymphocyte adenylyl cyclase by gold compounds represents a potential mode of action of these drugs in rheumatic disease.

Transcription factor NF-kappaB controls the expression of a number of genes including those for cell adhesion molecules such as E-selectin, ICAM- 1 and VCAM- 1. These cell adhesion molecules are known to play important roles in a critical step of tumor metastasis; the arrest of tumor cells on the venous or capillary bed of the target organ. NF-kappaB is activated by extracellular signals such as those elicited by the proinflammatory cytokines, TNF and IL-1. ...The adhesion of tumor cells to IL-1 beta-treated HUVEC /human umbilical vein endothelial cells/ was inhibited by gold compounds such as aurothiomalate.

Gold dermatosis is mediated, at least in part, by allergic mechanisms

Biological Half-Life · 5 items

12.5 days

Following single 10-mg doses of gold sodium thiomalate, serum gold concentrations showed a biphasic decline with a relatively rapid early phase (serum half-life about 43 hours) and a slow late phase (serum half-life about 6 days).

...Terminal log-linear phases corresponded to a mean disposition half-life of 25 days...

... the mean alpha half-lives were 0.738 and 1.78 hr for the iv and im routes, respectively. The corresponding terminal (beta) half-lives were 54.1 and 63.0 hr...

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
Water Solubility
Very soluble in water. Practically insoluble in alcohol, ether
Merck
14 · 14,4518
FDA UNII
4768 ZY6GM · E4768ZY6GM
NCI Drug Dictionary
Myochrysine
ATC code
1 CB01 · M01CB01
Protein binding
85 · 85-95%
Excreted unchanged in urine
Majority
Biological half-life
5 · 5-6 days / -
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H317-H332
Precautionary statements
261 · P261-P280g-P301+P312a-P304+P340-P321-P501a
Hazard Codes
Xn
Risk Statements
20 · 20/21/22-43
Safety Statements
36 · 36
WGK Germany
3 · 3
RTECS
5435000 · MD5435000
Hazardous Substances Data
12244 · 12244-57-4(Hazardous Substances Data)
Medical Surveillance · 1 item

Blood dyscrasia due to gold toxicity is rare, but because of the potential serious consequences it must be constantly watched for and recognized early by frequent blood examinations done throughout treatment. granulocytopenia, thrombocytopenia with or without purpura, eosinophilia, and hypoplastic and aplastic anemia, have been reported. These reactions may occur separately of in combinations.

Human Toxicity Excerpts · 5 items

/CASE REPORTS/ A 53-year-old male was accidentally injected with an intramuscular dose of 450 mg of ... /gold sodium thiomalate/. Palpebral edema and rash were observed within 30 minutes. The blood gold levels reach 2970 ug/dlL without significant toxicity. The patient was treated with BAL (British anti-lewisite) and recovered.

/HUMAN EXPOSURE STUDIES/ .../The authors/ investigated whether allergic mechanisms are involved in dermatosis induced by gold sodium thiomalate (GSTM). Thirteen gold dermatosis patients, 15 arthritis patients without any side-effects from GSTM and 11 healthy controls participated in the study. Venous blood lymphocytes from these subjects were cultured with GSTM and gold sodium thiosulfate (GSTS) in the lymphocyte proliferation test (LPT). In some cases, interferon-gamma-producing cells were enumerated in vitro (T-cell ELISpot). The subjects were also patch-tested with GSTM and GSTS. The LPT to either GSTM, GSTS or both was positive in 12 of 13 patients with gold dermatosis. In the arthritis patient group without side-effects from gold, the LPT gave two false-positive results and in the healthy control group the LPT was falsely positive with one subject. T-cell ELISpot was positive in four of six gold dermatosis patients and negative in the arthritis and healthy control groups. Only one patient who also developed contact dermatitis from gold jewelry was positive to gold in the patch test.

/SIGNS AND SYMPTOMS/ Dermatitis is the most common reaction. Any eruption, especially if pruritic, that develops with treatment with myochrysine should be considered a reaction to gold until proven otherwise. Pruritus often exists before dermatitis becomes apparent, and there fore should be considered a warning signal of impending cutaneous reaction. The most serious form of cutaneous reaction is generalized exfoliative dermatitis which may lead to alopecia and shedding of nails. Gold dermatitis may be aggravated by exposure to sunlight or an actinic rash may develop.

/SIGNS AND SYMPTOMS/ Stomatitis is the second most common adverse reaction. Shallow ulcers on the buccal membranes, on the borders of the tongue and on the palate, or on the pharynx may occur as the only adverse reaction, or along with dermatitis. Sometimes diffuse glossitis or gingivitis develops. A metallic taste may precede these oral mucous membrane reactions and should be considered a warning signal.

For more Human Toxicity Excerpts (Complete) data for GOLD SODIUM THIOMALATE (6 total), please visit the HSDB record page.

Non-Human Toxicity Excerpts · 5 items

/LABORATORY ANIMALS: Acute Exposure/ ... Gold sodium thiomalate (AuTM) ...administered to Sprague-Dawley rats and three strains of mice, Swiss-Webster, C3H/HeJ, and DBA/2J, was studied with regard to its effect on liver and renal monooxygenases, metallothionein contents, and serum levels of alanine aminotransferase and urea nitrogen...Benzo(a)pyrene hydroxylase and benzphetamine N-demethylase activities were not altered by AuTM in livers of rats and the three strains of mice. Benzo(a)pyrene hydroxylase activity was significantly decreased in rat kidney, whereas this enzyme activity was not affected in the kidneys of mice. In rats, AuTM caused a sevenfold induction in liver metallothionein, while in mice, liver metallothionein was induced twofold in Swiss-Webster mice and about fivefold in the inbred strains. AuTM caused minimal changes in renal metallothionein contents in the three strains of mice studied. Serum alanine amino-transferase, an indicator of hepatotoxicity, was not altered by AuTM in rats and mice studied. Blood urea nitrogen, an indicator of kidney dysfunction, was increased threefold in rats, but not in AuTM-treated mice. These data demonstrate that AuTM, a nephrotoxic agent in rats and humans, showed no nephrotoxic effects in the mouse strains studied here.

/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ ... A modest nephrosis in rats following ip administration of aurothiomalate can be induced and is manifested by polyuria and proteinuria. These symptoms rapidly subside following treatment, although histological signs of permanent injury are evident several weeks later. /Aurothiomalate/

/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Sodium aurothiomalate (monogold monosodium mono-hydrogen sulfidobutanedioate/, gold sodium thiomalate)/, an anti-rheumatoid gold agent, was injected s.c. every other day for three times or given in drinking water daily for two weeks to Balb/C mice that were inoculated with syngeneic Meth/A cells i.p. ...Statistically significant effects on survivals were obtained by 30 mg/kg/day s.c. or 75 mg/kg/day p.o. of gold. A dose of less than 12.5 mg/kg/day s.c. adversely affected the survival /of the animals/. ... No significant toxicity of gold was observed at doses up to 125 mg/kg/day.

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ studies in inbred mice have also demonstrated that that chronic treatment with disodium gold (I) thiomalate produced immune response to gold (III) in all A.SW mice, in about 70% of C57 BL/6 mice, and in none of the DBA/2 mice, clearly implicating genetic factors. These studies demonstrated that the strong immune response elicited were directed towards the gold (III) compounds, AuCl3 and HAuCl4, and that these dose-dependant responses were both T cell dependant and specific. It appears that in order to induce T cell sensitization, gold has to exist in the Au (III) state. Au (III) is a powerful thiol oxidizer and protein cross-linker, and in all likelihood, it is in this capacity that Au (III) alters proteins to create the final epitope(s) that are seen by responding T cells. /Gold sodium thiomalate/

For more Non-Human Toxicity Excerpts (Complete) data for GOLD SODIUM THIOMALATE (6 total), please visit the HSDB record page.

Antidote and Emergency Treatment · 5 items

When severe reactions to gold occur, corticosteroids, dimercaprol (a chelating agent), or penicillamine may be given to aid recovery. Prednisone ... is recommended to manage severe renal, hematologic, pulmonary, or enterocolic reactions to gold. Dimercaprol may be used together with corticosteroids to facilitate removal of the gold when corticosteroid treatment alone is ineffective.

Treatment with myochrysine /gold sodium thiomalate/ should be discontinued immediately when toxic reactions occur. Minor complications such as localized dermatitis, mild stomatitis or slight proteinuria generally require no other therapy and resolve spontaneously with suspension of myochrysine /gold sodium thiomalate/. Moderately severe skin and mucous membrane reactions often benefit from topical corticosteroids, oral antihistaminics, and soothing or anesthetic lotions.

For serious renal, hematologic, pulmonary, and enterocolitic complications, high doses of systemic corticosteroids are recommended. The optimum duration of corticosteroid treatment varies with response of the individual patient. Therapy may be required for many months when adverse effects are unusually severe or progressive.

In patients whose complications do not improve with high dose corticosteroid treatment, or who develop significant steroid related adverse reactions, a chelating agent may be given to enhance gold excretion. Dimercaprol (BAL) has been used successfully, but patients must be monitored carefully as numerous untoward reactions may attend it use. Corticosteroids and chelating agents may be used concomitantly.

For more Antidote and Emergency Treatment (Complete) data for GOLD SODIUM THIOMALATE (7 total), please visit the HSDB record page.

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
3
rtecs
MD5435000
risk_code
20/21/22-43
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
36
Hazard statements
H302-H317-H332
Precautionary statements
P261-P280g-P301+P312a-P304+P340-P321-P501a
Hazardous Substances Data
12244-57-4(Hazardous Substances Data)

Four normal male volunteers participated in a study designed to examine the disposition of gold given intramuscularly as gold sodium thiomalate. Blood samples were collected for 32 days following the administration of 10 mg of gold sodium thiomalate. .... Terminal log-linear phases corresponded to a mean disposition half-life of 25 days. ...

Metabolism/Metabolites · 2 items

No data available.

For a patient receiving gold sodium thiomalate the principal gold species in the urine is [Au(CN)2]-, which is also seen in a low molecular weight infiltrate of the blood

MeSH Pharmacological ClassificationDrugs that are used to treat RHEUMATOID ARTHRITIS.
Absorption, Distribution and Excretion · 6 items

Gold sodium thiomalate solutions are rapidly absorbed following IM injection, with peak serum concentrations occurring in 3-6 hours.

The major route of elimination of an IV dose of gold sodium thiomalate is urinary excretion, with a mean of 35% of the dose found in the urine in ten days. Fecal elimination accounts for an additional 9.4% of the IV dose excreted in ten days, probably as a result of biliary secretion.

The apparent volume of distribution is 0.26 +/- 0.051 kg-1

7.0 ml/ kg/day

Higher tissue levels occur with parenteral gold salts, with a mean steady state plasma level of 1 to 5 ug/ml. Drug is distributed widely throughout the body in lymph nodes, bone marrow, kidneys, liver, spleen, and tissues. About 85% to 90% is protein-bound.

Gold has been shown to cross the placenta in pregnant women receiving gold sodium thiomalate. Small amounts of gold have been shown to be distributed into milk in women receiving ... gold sodium thiomalate.

Uses & manufacturing

UsesMEDICATION
Methods of Manufacturing... A solution of thiomalic acid and 3 equivalents of sodium hydroxide are mixed with an aqueous suspension of gold(I)iodide. The product, a mixture of the mono- and disodium salts, is precipitated by the addition of ethanol.
Formulations/Preparations · 2 items

Parenteral: Injection, for IM use only, 50 mg/ml; Aurolate (with benzyl alcohol 0.5%), Taylor

Myochrysine is supplied as a solution for intramuscular injection containing 50 mg of gold sodium thiomalate per ml.

Applications

UsesMedicine (antirheumatic).

UsesSodium aurothiomalate(I) is useful for high mobility group box chromosomal protein 1 western blotting.

Additional notes

DefinitionWhite to yellowish-white powder; odorless; metallic taste. Affected by light. Very soluble in water; practically insoluble in alcohol and ether; aqueous solutions are colorless to pale yellow; pH (5% solution) 5.8–6.5.